A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt.
J Pharm Policy Pract
; 15(1): 10, 2022 Mar 01.
Article
in En
| MEDLINE
| ID: mdl-35232487
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Health_economic_evaluation
/
Prognostic_studies
Language:
En
Journal:
J Pharm Policy Pract
Year:
2022
Document type:
Article
Affiliation country:
Egypt
Country of publication:
United kingdom